Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
startups
archive
artificial intelligence
azacitidine
beta-thalassemia
boston
boston blog main
boston top stories
dacogen
deals
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
health
insulated genomic domains
kaleido biosciences
life sciences
machine learning
mahesh karande
medical
medicine
national blog main
national top stories
new york blog main
new york top stories
omega therapeutics
panobinostat
pharmaceuticals
research
reverie labs
richard young
robert gould
rudolf jaenisch
san francisco blog main
san francisco top stories
What
developing
3
×
drugs
3
×
research
3
×
biotech
called
medicines
new
aims
algorithms
approach
based
batch
bottlenecks
clinical
combinator’s
common
commonly
cost
debuts
development
diabetes
dollars
drug
epigenetic
epigenetics
field
fix
flagship’s
increased
issues
joins
know
labs
latest
learning
linked
machine
medication
men
millions
Language
unset
Current search:
research
×
developing
×
drugs
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@slashgear.com
5 years ago
Common prostate drugs linked to diabetes: What you need to know
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
